Terms & Conditions

We have Recently updated our Terms and Conditions. Please read and accept the terms and conditions in order to access the site

Current Version: 1

Privacy Policy

We have Recently updated our Privacy Policy. Please read and accept the Privacy Policy in order to access the site

Current Version: 1

COPD Article One

COPD – An indication for the Airnergy Spirovital prophylaxis and therapy

Article written by Prof. Dr. med. Klaus Jung

The change of climate from summer to winter often leads to a worsening of chronic obstructive pulmonary disease (COPD) or to more people becoming afflicted. Even in Germany up to 20% of all adults are affected. A new scientific verified natural remedy causes a stir of interest.

 Most of the time an acute bronchitis starts harmlessly by an inflammatory respiratory disease caused by viruses showing all typical symptoms and lasts up to four weeks. If it persists for a minimum of three months each year over a period of more than two years, then it becomes chronic. The chronic obstructive bronchitis shows a measurable constriction of the respiratory tract. If in addition there is a dilation of the terminal bronchioles (emphysema), which results in the destruction of alveoli then the worst degree is reached. The biggest cause is the inhaled smoke of cigarettes. Affected people suffer from an enormous production of phlegm in the respiratory tract, swelling and inflammation of the mucous membrane, overstrain of the heart and a low oxygen supply in all organ systems.

A shortness of breath can occur in a state of exertion or in an advanced state of the disease even in a state of rest. Other symptoms are a faster heartbeat, years of coughing and phlegm production (especially in winter), blue lips or extremities and last but not least an increasing right-sided heart failure.

Therapy is difficult. Every kind of inflammation of the respiratory tract endangers life and can be avoided with an appropriate lifestyle. If already afflicted, an inflammation should be treated with strong antibiotics immediately. Constant medication (e.g. anti-inflammatory medicine and medicine for removing phlegm as well as cortisol) is necessary, a physical therapy (breathing exercise) reasonable.

 In addition to conventional standard therapies the Spirovital Therapy has been used with almost sensational success by an increasing number of therapists during the last few years (Patients reports: “since starting the treatment three weeks ago, FEV1 rose from 20 to more than 40 per cent, removal of phlegm is optimal, normal oxygen saturation”; “clear improvement of subjective wellbeing”; “coughing up more or more liquid phlegm”; “less medicine, improvement of the lung function, increase of level of energy”; “obvious increase in performance”).

The physiological effects of Spirovitalisation can be summed up with an increase of oxygen supply in the periphery (better loosening of the bond between oxygen and the haemoglobin of the erythrocytes), a better utilization in the cells’ power stations (mitochondria) for the production of ATP and an increase in neutralisation of oxygen radicals (higher production when suffering from COPD).

 According to experts the most reliable parameter for observing the development of the disease and to review the success of a COPD therapy is the FEV1 (one-second capacity; the amount of air which can be exhaled within one second after having inhaled deeply). As far as possible the FEV1 was measured before and after COPD patients had used the Spirovital Therapy. In the majority of all cases the FEV1 value was better after the treatment.

In both clinical and user studies the absorption of oxygen and the oxygen saturation increased with 44 healthy test persons (15a-59a) after Spirovitalisation while the amount of oxygen in the exhaled air, the breathing frequency and the heart frequency were clearly reduced. This indicates an economisation of the metabolism, improvement of the energy consumption, increase of the utilization of oxygen and a stimulus for regeneration processes. In studies with 19 COPD patients (27a-91a, duration of disease 2 – 92 years) the results from the studies with healthy test persons were confirmed (improvement of subjective wellbeing, increase of the walking distance and FEV1 value, reduction of inflammation activity and bacterial infection, clear reduction of respiratory tract resistance, increase of immune competence). Therefore, it is not surprising that in a survey to therapists, as well as users of the Spirovital Therapy express their support for this natural remedy (which energises all organ systems, especially those which are highly dependent on oxygen) to be used in addition to conventional therapies.